lead sulfide has been researched along with 3-mercaptopropionic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lonergan, MC; Moody, IS; Nason, JA; Stankus, DP; Tanguay, RL; Truong, L | 1 |
| Choi, ES; In, SI; Kim, E; Kim, HR; Kim, JH; Lee, BR | 1 |
2 other study(ies) available for lead sulfide and 3-mercaptopropionic acid
| Article | Year |
|---|---|
Differential stability of lead sulfide nanoparticles influences biological responses in embryonic zebrafish.
Topics: 3-Mercaptopropionic Acid; Animals; Biological Transport; Chemical Precipitation; Dose-Response Relationship, Drug; Ectogenesis; Embryo, Nonmammalian; Lead; Ligands; Materials Testing; Metal Nanoparticles; Models, Animal; Oxidation-Reduction; Particle Size; Solubility; Sulfides; Surface Properties; Teratogens; Unithiol; Zebrafish | 2011 |
Carcinogenic activity of PbS quantum dots screened using exosomal biomarkers secreted from HEK293 cells.
Topics: 3-Mercaptopropionic Acid; Biomarkers, Tumor; Carcinogens; Chemokine CXCL5; Coated Materials, Biocompatible; Comet Assay; DNA Damage; Exosomes; Gene Expression Regulation; HEK293 Cells; Humans; Interleukin-8; Lead; MicroRNAs; Proteomics; Quantum Dots; Sulfides; Tumor Suppressor Protein p53 | 2015 |